When to Perform Bladder Catheterization in Fast-track Hip and Knee Arthroplasty
Launched by RIGSHOSPITALET, DENMARK · Apr 29, 2014
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • planned for elective total hip or knee arthroplasty
- • given written informed consent for participation
- Exclusion Criteria:
- • can't co-operate to participation
- • can't speak or understand danish
- • preoperative use of urinary bladder catheterization
- • using haemodialysis
- • previous cystectomy
- • need for permanent urinary bladder catheter during surgery (decided by anaesthesiologist and/or surgeon)
- • Pregnant or given birth within the last 6 months
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Farsoe, , Denmark
Hellerup, , Denmark
Vejle, , Denmark
Patients applied
Trial Officials
Lars Bjerregaard, MD
Principal Investigator
Rigshospitalet, Copenhagen university, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials